PhageTech Secures $2,400,000 Series A Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d30ddd19-5177-4cb8-944f-87c61637c242 - Date
9/30/2015 - Company Name
PhageTech - Mailing Address
4 Corporate Plaza Newport Beach, CA 92660 USA - Company Description
PhageTech, Inc. is a California based development stage company with an innovative platform that employs a bacteriophage substrate for detecting analytes in urine, blood and most any other body fluid. This technology promises to offer equal or better performance against antibody based assays. - Website
http://www.phagetech.com - Transaction Type
Venture Equity - Transaction Amount
$2,400,000 - Transaction Round
Series A - Proceeds Purposes
Proceeds will be used to complete development and FDA clearance of its revolutionary PhageTech Biosensor technology. - M&A Terms
- Venture Investor
Mark IV Capital - Venture Investor
Black River Asset Management
